INO:NASDAQ
Inovio Pharmaceuticals Inc
၁.၄၂ US$
arrow_downward
-၀.၇၀%(-၀.၀၁၀၀) 1D
နို ၁၆, GMT-၅ ၁၃:၂၃:၅၃ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
၁.၄၂ US$
High
၁.၄၈ US$
Low
၁.၃၇ US$
Mkt. cap
၂၆.၆၀ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၃.၃၉ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
Open
၁.၄၂ US$
High
၁.၄၈ US$
Low
၁.၃၇ US$
Mkt. cap
၂၆.၆၀ ကုဋေ
Avg. vol.
၁.၉၃ ကုဋေ
Volume
၃.၃၉ သန်း
52-wk high
၂.၇၂ US$
52-wk low
၀.၅၇ US$
EPS
-၀.၈၀ US$
Beta
၁.၇၁
Shares outstanding
၁၈.၇၃ ကုဋေ
No. of employees
၁၁၂
News stories
From web sources and news partners
ChartMill
·
ပြီးခဲ့သည့် ၄၈ မိနစ်
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
ပြီးခဲ့သည့် ၅၃ မိနစ်
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
ပြီးခဲ့သည့် ၅၄ မိနစ်
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
ပြီးခဲ့သည့် ၂ နာရီ
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc